Number of the records: 1  

Bortezomib alone and in combination with salinosporamid A induces apoptosis and promotes pheochromocytoma cell death in vitro and in female nude mice

  1. TitleBortezomib alone and in combination with salinosporamid A induces apoptosis and promotes pheochromocytoma cell death in vitro and in female nude mice
    Author Bullová Petra SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV
    Co-authors Cougnoux A.

    Kopáček Juraj 1963 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV    ORCID

    Pacak K.

    Source document Endocrinology. Vol. 158, no. 10 (2017), p. 3097-3108
    Languageeng - English
    CountryUS - United States of America
    Document kindrozpis článkov z periodík (rbx)
    CitationsYU, Run. Proteasome Inhibitors: A Potential Medical Therapy for Malignant Pheochromocytoma. In ENDOCRINOLOGY. ISSN 0013-7227, 2017, vol. 158, no. 10, pp. 3083-3085.
    JIN, Shidai - HE, Jing - LI, Jun - GUO, Renhua - SHU, Yongqian - LIU, Ping. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1. In THORACIC CANCER. ISSN 1759-7706, 2018, vol. 9, no. 10, pp. 1262-1270.
    RYU, Sunhyo - AHN, Yun Jeong - YOON, Chakeong - CHANG, Jeong Hwan - PARK, Yoonkyung - KIM, Tae-Hyoung - HOWLAND, Amanda R. - ARMSTRONG, Cheryl A. - SONG, Peter I. - MOON, Ae Ran. The regulation of combined treatmentinduced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells. In BMC CANCER. ISSN 1471-2407, 2018, vol. 18, no., pp.
    WANG, Hua - ZHANG, Shu - ZHANG, Aihong - YAN, Cunling. Propofol Prevents the Progression of Malignant PCC In Vitro and In Vivo. In DNA AND CELL BIOLOGY. ISSN 1044-5498, 2018, vol. 37, no. 4, pp. 308-315.
    PRATHEESHKUMAR, Poyil - SIRAJ, Abdul K. - DIVYA, Sasidharan Padmaja - PARVATHAREDDY, Sandeep Kumar - BEGUM, Rafia - MELOSANTOS, Roxanne - AL-SOBHI, Saif S. - AL-DAWISH, Mohammed - AL-DAYEL, Fouad - AL-KURAYA, Khawla S. Downregulation of SKP2 in Papillary Thyroid Cancer Acts Synergistically With TRAIL on Inducing Apoptosis via ROS. In JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. ISSN 0021-972X, 2018, vol. 103, no. 4, pp. 1530-1544.
    TUNDO, G.R. - SBARDELLA, D. - SANTORO, A.M. - COLETTA, A. - ODDONE, F. - GRASSO, G. - MILARDI, D. - LACAL, P.M. - MARINI, S. - PURRELLO, R. - GRAZIANI, G. - COLETTA, M. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges. In PHARMACOLOGY & THERAPEUTICS. ISSN 0163-7258, SEP 2020, vol. 213.
    BASLER, M. - GROETTRUP, M. Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy. In GENES AND IMMUNITY. ISSN 1466-4879, NOV 2020, vol. 21, no. 5, p. 273-287.
    HARRIS, M.A. - MILES, M.A. - SHEKHAR, T.M. - CERRA, C. - GEORGY, S.R. - RYAN, S.D. - CANNON, C.M. - HAWKINS, C.J. The Proteasome Inhibitor Ixazomib Inhibits the Formation and Growth of Pulmonary and Abdominal Osteosarcoma Metastases in Mice. In CANCERS. MAY 2020, vol. 12, no. 5.
    DILLON, J.S. - BUSHNELL, D. - LAUX, D.E. High-specific-activity (131)iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma. In FUTURE ONCOLOGY. ISSN 1479-6694, APR 2021, vol. 17, no. 10, p. 1131-1141.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2017
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1210/en.2017-00592
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201720164.286Q12.175Q1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.